Mirvald Cristian, Garaz Radion, Sinescu Ioanel, Preda Adrian, Labanaris Apostolos, Yossepowitch Ofer, Tsaur Igor, Surcel Cristian
Department of Urology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
"Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
J Clin Med. 2024 Aug 18;13(16):4879. doi: 10.3390/jcm13164879.
Penile cancer (PeCa) is a rare urological malignancy characterized by significant geographical variations in both incidence and mortality rates. Due to its rarity and the consequent lack of randomized trials, current management is based on retrospective studies and small prospective trials. In addition, both the diagnostic pathways and treatment strategies exhibit substantial heterogeneity, differing significantly between less-developed and well-developed countries. The prognosis of PeCas is determined by the presence and extent of regional lymph node (LN) involvement. Therefore, the early detection and treatment of LN metastasis is paramount to ensure better outcomes. In recent decades, overall survival of PeCas has increased, mainly due to advancements in imaging techniques and risk stratification. We aim to provide an overview of the current role of PET CT imaging in the management of patients with PeCa.
阴茎癌(PeCa)是一种罕见的泌尿系统恶性肿瘤,其发病率和死亡率在地域上存在显著差异。由于其罕见性以及随之而来的缺乏随机试验,目前的治疗基于回顾性研究和小型前瞻性试验。此外,诊断途径和治疗策略都表现出很大的异质性,在欠发达国家和发达国家之间存在显著差异。阴茎癌的预后取决于区域淋巴结(LN)受累的存在和程度。因此,早期检测和治疗LN转移对于确保更好的结果至关重要。近几十年来,阴茎癌的总体生存率有所提高,主要归功于成像技术和风险分层的进步。我们旨在概述PET CT成像在阴茎癌患者管理中的当前作用。